The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two ...
Jun 17, 2013
4.9 / 5 (27) | 12 |
Alzheimer's, schizophrenia, and autism now can be studied with mature brain cells reprogrammed from skin cells
Difficult-to-study diseases such as Alzheimer's, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative new method for obtaining mature brain cells called neurons ...
Jun 06, 2013
5 / 5 (3) | 0 |